246 related articles for article (PubMed ID: 24066851)
1. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
[TBL] [Abstract][Full Text] [Related]
2. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Steinacker P; Hendrich C; Sperfeld AD; Jesse S; von Arnim CA; Lehnert S; Pabst A; Uttner I; Tumani H; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph A; Neumann M; Otto M
Arch Neurol; 2008 Nov; 65(11):1481-7. PubMed ID: 19001167
[TBL] [Abstract][Full Text] [Related]
4. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Majumder V; Gregory JM; Barria MA; Green A; Pal S
BMC Neurol; 2018 Jun; 18(1):90. PubMed ID: 29954341
[TBL] [Abstract][Full Text] [Related]
6. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
[TBL] [Abstract][Full Text] [Related]
7. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP
Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086
[TBL] [Abstract][Full Text] [Related]
9. Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS.
Nozaki I; Arai M; Takahashi K; Hamaguchi T; Yoshikawa H; Muroishi T; Noguchi-Shinohara M; Ito H; Itokawa M; Akiyama H; Kawata A; Yamada M
Intern Med; 2010; 49(12):1209-12. PubMed ID: 20558945
[TBL] [Abstract][Full Text] [Related]
10. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis.
Beyer L; Günther R; Koch JC; Klebe S; Hagenacker T; Lingor P; Biesalski AS; Hermann A; Nabers A; Gold R; Tönges L; Gerwert K
Ann Clin Transl Neurol; 2021 Jan; 8(1):271-277. PubMed ID: 33263951
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis.
Verstraete E; Kuiperij HB; van Blitterswijk MM; Veldink JH; Schelhaas HJ; van den Berg LH; Verbeek MM
Amyotroph Lateral Scler; 2012 Sep; 13(5):446-51. PubMed ID: 22873561
[TBL] [Abstract][Full Text] [Related]
13. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Patients with and without the C9ORF72 Hexanucleotide Expansion.
Junttila A; Kuvaja M; Hartikainen P; Siloaho M; Helisalmi S; Moilanen V; Kiviharju A; Jansson L; Tienari PJ; Remes AM; Herukka SK
Dement Geriatr Cogn Dis Extra; 2016; 6(1):142-9. PubMed ID: 27195002
[TBL] [Abstract][Full Text] [Related]
15. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.
Hishizawa M; Yamashita H; Akizuki M; Urushitani M; Takahashi R
Neurochem Int; 2019 Mar; 124():41-45. PubMed ID: 30578840
[TBL] [Abstract][Full Text] [Related]
16. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases.
Feneberg E; Steinacker P; Lehnert S; Schneider A; Walther P; Thal DR; Linsenmeier M; Ludolph AC; Otto M
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):351-6. PubMed ID: 24834468
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers for Alzheimer's disease in patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis with the C9ORF72 repeat expansion.
Kämäläinen A; Herukka SK; Hartikainen P; Helisalmi S; Moilanen V; Knuuttila A; Jansson L; Tienari PJ; Remes AM
Dement Geriatr Cogn Disord; 2015; 39(5-6):287-93. PubMed ID: 25791939
[TBL] [Abstract][Full Text] [Related]
18. [Biomarkers for amyotrophic lateral sclerosis].
Tokuda T
Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
[TBL] [Abstract][Full Text] [Related]
20. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.
Borroni B; Benussi A; Archetti S; Galimberti D; Parnetti L; Nacmias B; Sorbi S; Scarpini E; Padovani A
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):86-91. PubMed ID: 25352065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
